Pharmaceutical company Sanofi is recalling all of its injectors used to treat severe allergic reactions.
The French drug and vaccine maker, whose injectors compete with Mylan’s EpiPen, is recalling all Auvi-Q injections currently on the U.S. market, which is about 490,000 packs, ABC reports, over concerns that they may not administer the correct amount of the drug.
Sanofi said it has received 26 reports of problems with the injectors, none of which resulted in the patient’s death. About 200,000 people in the United States use Sanofi’s product.
More Must-Reads from TIME
- Breaking Down the 2024 Election Calendar
- How Nayib Bukele’s ‘Iron Fist’ Has Transformed El Salvador
- What if Ultra-Processed Foods Aren’t as Bad as You Think?
- How Ukraine Beat Russia in the Battle of the Black Sea
- Long COVID Looks Different in Kids
- How Project 2025 Would Jeopardize Americans’ Health
- What a $129 Frying Pan Says About America’s Eating Habits
- The 32 Most Anticipated Books of Fall 2024
Write to Tessa Berenson Rogers at tessa.Rogers@time.com